Jason Xiaojun Cheng
University of Chicago, United States
Jason Cheng, MD, PhD, serves as an assistant professor and an attending physician in the Section of Hematopathology, University of Chicago. Dr. Cheng obtained his medical degrees Beijing Medical University and Kunming Medical University in China. He received his Ph.D., under the guidance of Dr. Rudy Juliano, the Chairman of Department of Pharmacology at University of North Carolina-Chapel Hill. He pursued his post-doctoral training in yeast genetics and gene regulation in the laboratory of Dr. Mark Ptashne, the winner of 1997 Albert Lasker Basic Medical Research Award, at Memorial Sloan Kettering Cancer Center in New York. Dr. Cheng completed his residency in anatomic and clinical Pathology and his fellowship in Hematopathology under the guidance of Dr. James W. Vardiman, one of the top authorities in diagnosis of hematologic diseases, at University of Chicago. Some of the highlights in Dr. Cheng’s scientific career include inventing a novel technology for identifying sequence-specific DNA-binding peptides for gene editing (US patent no 5,869,250, 1999), receiving the Cancer Research Foundation Young Investigator Award in 2014 and publishing multiple papers in high-impact factor journals including Leukemia, PNAS, Immunity and Molecular Cell.
Dr. Cheng’s research interests include epigenetics, transcriptional regulation and chromatin structure. His current research is focusing on the identification of of novel diagnostic biomarkers and therapeutic targets for hematologic diseases including myelodysplastic syndrome (MDS), myeloproliferative neoplasms, acute myeloid leukemia and lymphoid neoplasms.